Friday, June 04, 2021 11:40:49 AM
Posters https://www.allogene.com/resources/download/First-In-Human-Data-of-ALLO-501A.pdf https://www.allogene.com/resources/download/Safety-and-PK-PD-of-ALLO-647.pdf
Recent ALLO News
- Allogene Therapeutics Announces Q2 Investor Conference Participation • GlobeNewswire Inc. • 04/09/2024 12:30:00 PM
- Allogene Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update • GlobeNewswire Inc. • 03/14/2024 08:05:00 PM
- Allogene Therapeutics and Arbor Biotechnologies Announce Global Gene Editing Licensing Agreement to Support Advancement of Next-Generation Allogeneic CAR T Platform in Autoimmune Disease • GlobeNewswire Inc. • 03/12/2024 12:30:00 PM
- Allogene Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update • GlobeNewswire Inc. • 03/05/2024 01:30:00 PM
- Allogene Therapeutics Announces Participation in the 44th Annual TD Cowen Health Care Conference • GlobeNewswire Inc. • 02/28/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 01:30:30 PM
- Allogene Therapeutics to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments Related to the December 2020 Formation of the Allogene Overland Biopharm Joint Venture in Asia • GlobeNewswire Inc. • 02/16/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 10:45:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 10:25:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/22/2024 09:11:45 PM
- Allogene Therapeutics Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 01/16/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 01:00:31 PM
- Allogene Therapeutics and Foresight Diagnostics Announce Partnership to Develop MRD-based In-Vitro Diagnostic for Use in ALPHA3, the First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma • GlobeNewswire Inc. • 01/04/2024 09:15:00 PM
- Allogene Therapeutics Announces 2024 Platform Vision to Redefine the Future of CAR T Led by ALPHA3, the Industry's First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma • GlobeNewswire Inc. • 01/04/2024 09:05:00 PM
- Allogene Therapeutics to Host Conference Call Previewing its 2024 Platform Vision and Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/03/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 09:26:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 08:46:25 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/18/2023 09:17:30 PM
- Allogene Therapeutics Presents Comprehensive Safety Data of Proprietary Lymphodepletion Agent ALLO-647 at the 65th Annual Meeting of the American Society of Hematology • GlobeNewswire Inc. • 12/09/2023 05:00:00 PM
- Allogene Therapeutics Announces Participation in December Investor Conference • GlobeNewswire Inc. • 12/01/2023 01:30:00 PM
- Allogene Therapeutics Presents Preclinical Data on Next Generation Cloak™ and Dagger™ Technologies at the Society for Immunotherapy of Cancer Annual Meeting • GlobeNewswire Inc. • 11/03/2023 04:00:00 PM
- Allogene Therapeutics Presents Preclinical Data on a Novel Allogeneic CAR T Product Candidate Targeting Claudin18.2 at the Society for Immunotherapy of Cancer Annual Meeting • GlobeNewswire Inc. • 11/03/2023 04:00:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/02/2023 08:41:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/02/2023 08:06:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 08:03:27 PM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM